DeutschNewstral
Article
blogs.wsj.com on 2016-06-02 23:54
CFO Moves: Colfax Corp., Nektar Therapeutics, Western Refining Logistics
Related news
How Bempegaldesleukin Woes Have Impacted Nektar TherapeuticsForbes
Merck and TJX climb; Nektar Therapeutics slumpsreviewtimes.com- 35% Upside Likely For Nektar Therapeutics?Forbes
Nektar Therapeutics plans layoffs for Huntsville locationbizjournals.com- Nektar Therapeutics Stock Performance In The Pandemic vs 2008Forbes
Take-Two, SVB Financial and Nektar Therapeutics to Join S&P 500wsj.com- BNektar Therapeutics Stock Is Rising on Test Data for Cancer Drugbarrons.com
- MNektar Therapeutics shares slide 6.3% premarket after Goldman downgrades to sell from buymarketwatch.com
- LGlobal NK Cell Therapy Market Estimation 2021-2026 Analysis by Key Players like Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Dragonfly Therapeutics, etc. | Affluenceliverpoolstudentmedia.com
- CFO Moves: Western Refiningblogs.wsj.com
- Cognition Therapeutics names CFObizjournals.com
- MNektar Therapeutics stock drops after resultsmarketwatch.com
- CFoghorn Therapeutics CFO Leavesceoworld.biz
- Cesca Therapeutics names new CFObizjournals.com
- Andeavor Logistics moves Western Refining Logistics merger forwardbizjournals.com
- MBristol-Myers and Nektar Therapeutics to jointly develop cancer treatmentsmarketwatch.com
- BNektar Therapeutics Stock Tanks Nearly 40%2 min readbarrons.com
- MNektar Therapeutics surges 10% on $150 mln Eli Lilly dealmarketwatch.com